HealthyWomen spoke with Metri Bio CEO and co-founder Ashley Abel about the scientific insight that inspired the company, the limitations of existing endometriosis models, and Metri’s work to build patient-derived human tissue models for discovering targeted therapies. The conversation also explores why endometriosis should be understood as a full-body disease, not only a fertility condition, and the need for treatments that address its underlying biology.
